Gilead Sciences, Inc.
Close on Nov 20, 2026Market cap $206.43BP/E –Yield 1.90%
Gilead Sciences Wholesaler revenue concentration by Year
Wholesaler revenue concentration — Cardinal Health, Inc. (% of total revenues) (%)
Gilead Sciences Wholesaler revenue concentration: 2,900.0% in FY2025, unchanged from a year earlier.
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-24) ↗
Reported in Form 10-K Note 2 Summary of Significant Accounting Policies.
annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Wholesaler revenue concentration — Cardinal Health, Inc. (% of total revenues) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2,900.0% | 0.0 pts | Form 10-K (filed 2026-02-24) ↗ |
| FY2024 | Dec 31, 2024 | 2,900.0% | +100.0 pts | Form 10-K (filed 2026-02-24) ↗ |
| FY2023 | Dec 31, 2023 | 2,800.0% | +300.0 pts | Form 10-K (filed 2026-02-24) ↗ |
| FY2022 | Dec 31, 2022 | 2,500.0% | +300.0 pts | Form 10-K (filed 2025-02-28) ↗ |
| FY2021 | Dec 31, 2021 | 2,200.0% | +100.0 pts | Form 10-K (filed 2024-02-23) ↗ |
| FY2020 | Dec 31, 2020 | 2,100.0% | 0.0 pts | Form 10-K (filed 2023-02-22) ↗ |
| FY2019 | Dec 31, 2019 | 2,100.0% | – | Form 10-K (filed 2022-02-23) ↗ |
Cite this data
StockData. (2026). Gilead Sciences Wholesaler revenue concentration (%), annual FY2019–FY2025 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/conc-cardinal-rev
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.
See a number that looks wrong?